Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 06, 2021

SELL
$4.79 - $6.68 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

BUY
$5.35 - $6.35 $0 - $0
0 New
0 $0
Q1 2021

Apr 30, 2021

BUY
$5.68 - $7.87 $0 - $0
0 New
0 $0
Q4 2020

Jan 25, 2021

BUY
$5.25 - $8.56 $0 - $0
0 New
0 $0
Q3 2020

Oct 29, 2020

BUY
$5.78 - $7.47 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$4.5 - $7.02 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$2.87 - $5.49 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$3.84 - $4.86 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$4.86 - $6.05 $0 - $0
0 New
0 $0
Q3 2018

Oct 25, 2018

SELL
$6.89 - $7.78 $7,427 - $8,386
-1,078 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$5.19 - $7.25 $5,594 - $7,815
1,078 New
1,078 $0
Q3 2017

Oct 30, 2017

SELL
$2.22 - $2.73 $222 - $273
-100 Closed
0 $0
Q2 2016

Jun 03, 2019

BUY
N/A
100
100 $1,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $319M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.